Lipoprotein, Low Density, Removal
The Low Density Lipoprotein (LDL) Removal device is an extracorporeal system used in lipid apheresis to selectively remove low-density lipoprotein cholesterol from a patient's blood, used in the treatment of severe familial hypercholesterolemia in patients who cannot achieve adequate LDL reduction through diet and drug therapy alone. As a Class 3 device, it requires Premarket Approval (PMA) given the high risks associated with extracorporeal blood processing. No regulation number or medical specialty code is recorded, and it carries no implant or life-sustaining flags.
Basic Information
- Product Code
- MMY
- Device Class
- FDA class 3
- Medical Specialty
- Unknown
- Review Panel
- GU
- Submission Type
- 2
Device Characteristics
FEI Numbers
This FDA classification entry is associated with 5 FEI numbers. Click on an entry to view related FDA registrations.
Registration Numbers
This FDA classification entry is associated with 5 registration numbers. Click on an entry to view related FDA registrations.